Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells.
Am J Hematol
; 97(12): 1580-1588, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36068950
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos